As a healthcare-associated infection, Acinetobacter baumannii is becoming a more serious influence as antibiotic resistances rates rise, and policy must encourage strict hygeine compliance and careful drug choice to prevent major outbreaks in the future, according to a Review released on November 18, the The Lancet Infectious Diseases.

More: continued here

This entry was posted on Tuesday, December 2nd, 2008 at 5:12 am and is filed under Health Insurance / Medical Insurance. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.